돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2222673생성일: 2026년 10월 24일

Hydrochloric Acid → Sri 62320

https://huagongshe.com/ko/reaction/2222673

반응식

참여 물질

역할이름HCID투입량
반응물Hydrochloric AcidHCID 313—
반응물Sodium HydroxideHCID 14798—
반응물PitavastatinHCID 5282452—
반응물HCID 59712856HCID 59712856—
생성물Sri 62320HCID 23663976—

반응 단계

can be prepared from (E)-(3R,5S)-7-[3-(4-Fluoro-phenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-hept-6-enoic acid ((S)-1-phenyl-ethyl)-amide by hydrolysis with sodium hydroxide according to the procedure described above for the preparation of (E)-(3R,5S)-7-[2-Cyclopropyl-4-(4-fluoro-phenyl)-quinolin-3-yl]-3,5-dihydroxy-hept-6-enoic acid. After completion of the hydrolysis, excess sodium hydroxide is neutralised by addition of hydrochloric acid and the solvent is evaporated under reduced pressure. As a work-up variant, the residue is dissolved in water at 60-70° C. and the solution is allowed to cool down to room temperature. Crystallisation occurs. The formed suspension is cooled down to 5° C., stirred for several hours at this temperature to complete the crystallisation and the product is isolated by filtration. (E)-(3R,5S)-7-[3-(4-Fluoro-phenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-hept-6-enoic acid sodium salt is obtained as beige to yellow crystalline product.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07371865B2
출처 데이터셋uspto-grants-2008_05
ORD IDord-ff3e0b23a700424f9ec6ebe4b788f646
출처 메모uspto-grants-2008_05